NCT03382015View on ClinicalTrials.gov

Effect of BKR-013 on Average Daily Glucose Levels

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
OTHER

BKR-013 or Placebo

Encapsulated L-glutamine

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

Sponsors

Lead Sponsor

BioKier Inc.
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

BioKier Inc.

INDUSTRY